1. Home
  2. AVD vs TLSI Comparison

AVD vs TLSI Comparison

Compare AVD & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVD
  • TLSI
  • Stock Information
  • Founded
  • AVD 1969
  • TLSI 2010
  • Country
  • AVD United States
  • TLSI United States
  • Employees
  • AVD N/A
  • TLSI N/A
  • Industry
  • AVD Agricultural Chemicals
  • TLSI Medical Specialities
  • Sector
  • AVD Industrials
  • TLSI Health Care
  • Exchange
  • AVD Nasdaq
  • TLSI Nasdaq
  • Market Cap
  • AVD 171.3M
  • TLSI 166.8M
  • IPO Year
  • AVD N/A
  • TLSI N/A
  • Fundamental
  • Price
  • AVD $6.01
  • TLSI $4.76
  • Analyst Decision
  • AVD Strong Buy
  • TLSI Strong Buy
  • Analyst Count
  • AVD 3
  • TLSI 3
  • Target Price
  • AVD $16.67
  • TLSI $12.67
  • AVG Volume (30 Days)
  • AVD 258.2K
  • TLSI 65.5K
  • Earning Date
  • AVD 11-06-2024
  • TLSI 11-12-2024
  • Dividend Yield
  • AVD 2.01%
  • TLSI N/A
  • EPS Growth
  • AVD N/A
  • TLSI N/A
  • EPS
  • AVD N/A
  • TLSI N/A
  • Revenue
  • AVD $585,049,000.00
  • TLSI $24,736,000.00
  • Revenue This Year
  • AVD N/A
  • TLSI $61.24
  • Revenue Next Year
  • AVD $4.69
  • TLSI $47.32
  • P/E Ratio
  • AVD N/A
  • TLSI N/A
  • Revenue Growth
  • AVD 2.73
  • TLSI 67.75
  • 52 Week Low
  • AVD $4.95
  • TLSI $3.32
  • 52 Week High
  • AVD $14.28
  • TLSI $10.42
  • Technical
  • Relative Strength Index (RSI)
  • AVD 43.29
  • TLSI 38.74
  • Support Level
  • AVD $5.86
  • TLSI $4.43
  • Resistance Level
  • AVD $6.58
  • TLSI $5.32
  • Average True Range (ATR)
  • AVD 0.25
  • TLSI 0.37
  • MACD
  • AVD 0.12
  • TLSI -0.04
  • Stochastic Oscillator
  • AVD 48.18
  • TLSI 27.24

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: